39.30 USD
▲-0.20+1.71%
2026-08-03
市值
—
规模 AUM
$29.10M
EPS
—
股息率
—
52 周区间
27.54 – 41.30
成交量
4.72K
Beta
0.97
目标价
—
52W 低 27.5452W 高 41.30
价格走势
公司简介
The Franklin Genomic Advancements ETF (HELX) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed portfolio of global equity securities of companies relevant to genomic discovery. HELX was launched on Feb 25, 2020 and is issued by Franklin Templeton.